GlassScriptPhysician profile
Amy Wenzel
NPI 1932244852
$10,598.90
in general payments reported to CMS, 2019-2025
30 companies · $3,867 in 2025
The $3,867 reported for 2025 was more than what 97% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,677 · 2022: $1,049 · 2023: $2,592 · 2024: $1,413 · 2025: $3,867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,571 · Travel and Lodging: $2,192 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,570.67 |
| Travel and Lodging | $2,191.67 |
| Education | $109.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,010.10 | 2021-2025 | Watchman Access System, General - Therapies, Watchman Flx |
| Abbott Laboratories | $559.11 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Amgen INC. | $549.06 | 2021-2024 | Repatha |
| Medtronic, INC. | $533.10 | 2021-2024 | Reveal Linq, Micra, Linq II |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $412.89 | 2021-2025 | Lifevest |
| Edwards Lifesciences Corporation | $393.34 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals LP | $340.79 | 2021-2025 | Farxiga, Lokelma, Wainua |
| E.R. Squibb & Sons, L.L.C. | $317.18 | 2021-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $266.20 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $237.15 | 2021-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $225.70 | 2021-2025 | Jardiance |
| W. L. Gore & Associates, INC. | $215.79 | 2022-2023 | Gore Cardioform Septal Occluder |
| Philips North America LLC | $186.15 | 2024-2025 | Diagnostic Ecg Service, Mcot, (Ck4) Mcot |
| Atricure, INC. | $170.17 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $160.40 | 2021-2023 | Xifaxan |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $121.96 | 2025 | |
| Itamar Medical INC | $118.76 | 2023 | Watchpatone |
| Pfizer INC. | $115.89 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $113.74 | 2021-2025 | Verquvo, Capvaxive |
| Biotronik INC. | $109.80 | 2024-2025 | |
| Impulse Dynamics (USA) INC. | $92.51 | 2023-2024 | Optimizer, Optimizer |
| Kestra Medical Technology Services, INC. | $84.75 | 2025 | Assure Wcd |
| Cardiva Medical, INC. | $57.25 | 2021-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Abiomed | $54.46 | 2024-2025 | Impella |
| Lexicon Pharmaceuticals, INC. | $39.72 | 2024 | |
| Bridgebio Pharma, INC. | $31.69 | 2025 | Attruby |
| Novo Nordisk INC | $26.23 | 2024 | Wegovy |
| Amarin Pharma, INC. | $24.83 | 2022 | |
| Teleflex LLC | $18.18 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Wenzel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.